Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells

Blood

Volumn 99, Issue 6, 2002, Pages 2162-2171

  Mitsiades, Nicholas ^a,b   Mitsiades, Constantine S ^a,b   Poulaki, Vassiliki ^a,b   Anderson, Kenneth C ^a,b   Treon, Steven P ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INHIBITOR; BISINDOLYLMALEIMIDE; CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; CYCLOHEXIMIDE; DEXAMETHASONE; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL KILLING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIZATION; SIGNAL TRANSDUCTION;

EID: 0037085796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.6.2162     Document Type: Article

References (53)

1. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
2. Identification and characterization of a new member of the TNF family that induces apoptosis
3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand
4. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and express DR4 and DR5 receptors
5. Apoptosis control by death and decoy receptors
6. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
7. Safety and antitumor activity of recombinant soluble Apo2 ligand
8. TRAIL: A molecule with multiple receptors and control mechanisms
9. Apoptosis signaling by death receptors
10. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
11. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
12. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
13. Recombinant human TNF-related apoptosis inducing ligand (hu TRAIL) induces apoptosis of human multiple myetoma (MM) cells
14. TNF-related apoptosis-inducing ligand/Apo2L selectively induces apoptosis and overcomes drug resistance in multiple myeloma: Therapeutic applications
15. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
16. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis
17. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone
18. XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage
19. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis
20. TRAIL-induced apoptosis of thyroid cancer cells: Potential for therapeutic intervention
21. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells
22. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmateimide
23. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis
24. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB
25. Human astrocytic brain tumors express APO2L/TRAIL
26. APO2 ligand: A novel lethal weapon against malignant glioma?
27. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
28. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
29. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
30. Apoptosis-induced by TRAIL and TNF-alpha in human multiple myeloma cells is not blocked by BCL-2
31. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
32. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics [review]
33. TRAIL induces differentiation-stage specific apoptosis in B-cell malignancies, overcomes drug resistance in multiple myeloma and its antimyeloma effect is enhanced by doxorubicin NF-κB inhibition
34. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
35. CD95/Fas/Apo-1 mediated signal tranduction
36. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
37. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
38. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
39. Two CD95 (APO-I/Fas) signaling pathways
40. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2
41. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
42. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
43. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis
44. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
45. Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion
46. Inhibition of death receptor signals by cellular FLIP
47. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
48. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
49. I-FLICE a novel inhibitor of tumor necrosis factor receptor-1 - and CD-95-induced apoptosis
50. The receptor for the cytotoxic ligand TRAIL
51. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase
52. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
53. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control